Home/Filings/4/0001209191-23-047104
4//SEC Filing

Harford Simon N.R. 4

Accession 0001209191-23-047104

CIK 0001178879other

Filed

Aug 22, 8:00 PM ET

Accepted

Aug 23, 5:59 PM ET

Size

7.5 KB

Accession

0001209191-23-047104

Insider Transaction Report

Form 4
Period: 2023-08-21
Harford Simon N.R.
Chief Financial Officer
Transactions
  • Award

    Stock Options (right to buy)

    2023-08-21+189,043189,043 total
    Exercise: $12.62Exp: 2033-08-21Common Stock (189,043 underlying)
  • Award

    Common Stock

    2023-08-21+106,973106,973 total
Footnotes (2)
  • [F1]Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on August 21, 2024 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
  • [F2]These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.

Issuer

AMICUS THERAPEUTICS, INC.

CIK 0001178879

Entity typeother

Related Parties

1
  • filerCIK 0001443705

Filing Metadata

Form type
4
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 5:59 PM ET
Size
7.5 KB